Company performance
Current Price
as of Jan 23, 2025$2.53
P/E Ratio
N/A
Market Cap
$121.72M
Description
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Metrics
Overview
- HQAustin, TX
- SectorHealth Technology
- IndustryBiotechnology
- TickerSAVA
- Price$2.53-2.32%
Trading Information
- Market cap$121.72M
- Float86.89%
- Average Daily Volume (1m)3,113,567
- Average Daily Volume (3m)5,738,126
- EPS-$0.36
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$27.94M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$31.46M
- EV$1.22B
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.73
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset